Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J2ID
|
||||
| Former ID |
DNC011042
|
||||
| Drug Name |
6-chloro-N-(pyridin-3-yl)indoline-1-carboxamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551219] | ||
| Formula |
C14H12ClN3O
|
||||
| Canonical SMILES |
C1CN(C2=C1C=CC(=C2)Cl)C(=O)NC3=CN=CC=C3
|
||||
| InChI |
1S/C14H12ClN3O/c15-11-4-3-10-5-7-18(13(10)8-11)14(19)17-12-2-1-6-16-9-12/h1-4,6,8-9H,5,7H2,(H,17,19)
|
||||
| InChIKey |
LOMPSBWQXLVHJX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.